These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 34749208)

  • 1. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
    Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
    Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
    Zhou M; Chen Y; Gu X; Wang C
    Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer.
    Dai B; Ren LQ; Han XY; Liu DJ
    J Int Med Res; 2020 Mar; 48(3):300060519887637. PubMed ID: 31775549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report.
    Huang J; Li Y; Lu Z; Che Y; Sun S; Mao S; Lei Y; Zang R; Li N; Zheng S; Liu C; Wang X; Sun N; He J
    Cell Oncol (Dordr); 2019 Aug; 42(4):571-578. PubMed ID: 30887286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.
    Zhang JJ; Hong J; Ma YS; Shi Y; Zhang DD; Yang XL; Jia CY; Yin YZ; Jiang GX; Fu D; Yu F
    Dis Markers; 2021; 2021():6696198. PubMed ID: 33505535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer.
    Cai X; Lin L; Zhang Q; Wu W; Su A
    J Int Med Res; 2020 Jun; 48(6):300060520929167. PubMed ID: 32527185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
    Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
    J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Xia MD; Yu RR; Chen DM
    Front Immunol; 2021; 12():809325. PubMed ID: 35069594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
    Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
    Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic markers by weighted gene co-expression network analysis in non-small cell lung cancer.
    Chen B; Xie X; Lan F; Liu W
    Bioengineered; 2021 Dec; 12(1):4924-4935. PubMed ID: 34369264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
    Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
    J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
    Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.
    Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T
    Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.